[Diagnostic and therapeutic difficulties in neurocysticercosis: presentation of 6 cases and review of the literature] (Q80319496)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17497055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

[Diagnostic and therapeutic difficulties in neurocysticercosis: presentation of 6 cases and review of the literature] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17497055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

Enseñat J

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17497055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Martínez-Mañas R

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17497055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Horcajada JP

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17497055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

De Juan C

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17497055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Ferrer E

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17497055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17497055%20AND%20SRC:MED&resulttype=core&format=json

Neurocirugia (Asturias, Spain)

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17497055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17497055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

101-110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17497055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17497055%20AND%20SRC:MED&resulttype=core&format=json

Severe forms of neurocysticercosis: treatment with albendazole.

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Endoscopic removal of cysticercal cysts within the fourth ventricle. Technical note

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Endoscopic management of cysticercal cysts within the lateral and third ventricles

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Bioavailability of praziquantel increases with concomitant administration of food

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Interaction between grapefruit juice and praziquantel in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Results of surgical treatment of neurocysticercosis in 69 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Cysticercosis of the central nervous system. I. Surgical treatment of cerebral cysticercosis: a 23 years experience in the Hospital das Clínicas of Ribeirão Preto Medical School

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Current consensus guidelines for treatment of neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Neurocysticercosis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Pharmacokinetic study of praziquantel administered alone and in combination with cimetidine in a single-day therapeutic regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Inflammatory aneurysm due to neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Vaccines for prevention of cysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Optimization of the single-day praziquantel therapy for neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Albendazole metabolism in patients with neurocysticercosis: antipyrine as a multifunctional marker drug of cytochrome P450.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Effect of gender in the disposition of albendazole metabolites in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Cysticercosis cerebri

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Enzyme linked immunosorbent assay (ELISA) for the detection of IgG, IgM, IgE and IgA against Cysticercus cellulosae in cerebrospinal fluid of patients with neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Management of neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Neurocysticercosis and Population Movements: Analysis of 23 Imported Cases in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Serological screening for cysticercosis in mentally altered individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Effect of dose increase or cimetidine co-administration on albendazole bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Pharmacokinetic optimisation of the treatment of neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Therapy for Neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Therapy for neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Neurocysticercosis in the United States: review of an important emerging infection

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

Taenia antigens detection in the cerebrospinal fluid of patients with neurocysticercosis and its relationship with clinical activity of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1130-1473%2807%2970294-4

7 January 2021

10.1016/S1130-1473(07)70294-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17497055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference